What we do Ortin Global Ltd is a pharmaceutical manufacturer in India producing a wide range of formulations including tablets, capsules, and syrups for diverse therapeutic areas. |
Founded in 1,986 |
Market share A leading Indian pharma manufacturer with growing exports across Asia, Africa, and the Middle East. |
Problem solved Providing affordable, quality medicines for multiple health conditions including antibiotics, anti-diabetics, cardiac, and nutritional supplements. |
Top clients or who we serve Serves healthcare providers, pharmacies, and hospitals primarily in India and emerging international markets; B2B model. |
Key management - |
Our journey and innovations Founded in 1986, expanded manufacturing to WHO GMP standards, merged Vineet Laboratories in 2010, and diversified into bulk drugs and exports since 2006. |
Where we operate India with export markets in Asia, Africa, and the Middle East. |
Top products or what we offer Wide pharma portfolio: anti-arthritics, antibiotics, cardio drugs, anti-diabetic, vitamins, pediatric, dermatology and ENT products. |
Top brands - |
Raw materials needed Active pharmaceutical ingredients and excipients used in formulations production. |
Raw materials supplier - |
Recurring vs cyclical contribution Primarily recurring revenue through continuous pharmaceutical sales and exports. |
Our industry position Predominant Indian pharma manufacturer with recognized export credentials and upgraded manufacturing capabilities. |
Financial highlights FY25 revenue Rs. 34.22 Lakhs; net loss Rs. 84.64 Lakhs; ongoing efforts to improve profitability. |
Geographical revenue split Majority revenue from India; emerging exports contribute to growth potential. |
Order book - |
Whats driving growth Modernized facilities, expanded therapeutic range, export market penetration, and strategic mergers driving growth. |
Our future plans Construction of USFDA and European standard bulk drug manufacturing facility underway for enhanced capabilities. |
Our green promise Committed to pollution control and environmental compliance adhering to government directives. |
Our people and values Focus on ethical practices, compliance, and fostering a skilled workforce to maintain quality standards. |
Key challenges ahead Improving financial performance, meeting regulatory norms, and strengthening market presence amid industry competition. |
Interesting facts First Indian pharma to list on BSE-Indonext model enhancing investor reach in 2006. |
Risks and strategy Addressing financial losses with strengthened internal controls and expanding into high-margin pharmaceutical segments. |
